Drug intelligence / Profile preview

florfenicol

Development stage
Unknown
Lead developer
Merck Animal Health
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Intramuscular, Subcutaneous, Oral
01

Overview

Florfenicol is a synthetic, fluorinated analog of thiamphenicol and chloramphenicol, used exclusively in veterinary medicine. It is a broad-spectrum antibiotic with activity against many Gram-positive and Gram-negative bacteria. Florfenicol acts primarily as a bacteriostatic agent by binding to the 50S ribosomal subunit of susceptible bacteria, inhibiting peptidyl transferase activity and thereby blocking bacterial protein synthesis. At higher concentrations or against certain species, it may exhibit bactericidal effects. Florfenicol is approved for use in food animals such as cattle and swine for the treatment of respiratory diseases (e.g., bovine respiratory disease complex, swine respiratory disease complex) caused by pathogens including Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Actinobacillus pleuropneumoniae, Streptococcus suis, Bordetella bronchiseptica, Glaesserella parasuis (Haemophilus parasuis), Salmonella Choleraesuis among others[1][2][3][5][7]. It also has reported anti-inflammatory properties through reduction of immune cell proliferation and cytokine production[3]. Florfenicol’s structure makes it less susceptible to certain resistance mechanisms compared to its analogs[6]. Developed by Merck Animal Health.

Brand names
NUFLOR
Other names
LoncorLoncor 300Loncor300Loncor-300florfenicol injectable solution
02

Targets

PTC (50S ribosomal peptidyl transferase center)

Beyond the preview

Go deeper on florfenicol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on florfenicol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call